- Home
- NDLS vs SCNX Comparison
NDLS vs SCNX Comparison
Compare NDLS & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NDLS | SCNX |
|---|---|---|
| Founded | 1995 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.7M | 16.2M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NDLS | SCNX |
|---|---|---|
| Price | $13.61 | $0.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 21.2K | ★ 361.9K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $495,089,000.00 | $3,831,778.00 |
| Revenue This Year | N/A | $1,097.38 |
| Revenue Next Year | N/A | $239.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.37 | ★ 30.72 |
| 52 Week Low | $0.47 | $0.24 |
| 52 Week High | $19.00 | $2.60 |
Technical Indicators
Market Signals| Indicator | NDLS | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 33.09 |
| Support Level | $12.83 | $0.30 |
| Resistance Level | $13.95 | $0.43 |
| Average True Range (ATR) | 0.83 | 0.02 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 14.72 | 0.64 |
Price Performance
Historical ComparisonAbout NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services. It is focused on offering customers flavorful, cooked-to-order dishes in a warm and welcoming environment at an attractive value. It has approximately 340 company-owned restaurants and 83 franchise restaurants in 31 states.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.